Project VSV-EBOVAC – Vaccine Safety and immunogenicity signatures of human responses to VSV-ZEBOV

Basic data

Acronym:
VSV-EBOVAC
Title:
Vaccine Safety and immunogenicity signatures of human responses to VSV-ZEBOV
Duration:
01/03/2015 to 28/02/2018
Abstract / short description:
Acquire knowledge of the innate and adaptive immune responses elicited in humans by VSV-ZEBOV vaccination, with specific emphasis on transcriptomics and metabolomics signatures. For CERMEL: A twelve month follow up visit.

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Department VII, Tropical Medicine
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

Help

will be deleted permanently. This cannot be undone.